Suppr超能文献

孟加拉国新冠疫苗的副作用以及对新冠病毒及其疫苗的认知:一项横断面研究。

Side effects of COVID-19 vaccines and perceptions about COVID-19 and its vaccines in Bangladesh: A Cross-sectional study.

作者信息

Mohsin Md, Mahmud Sultan, Uddin Mian Ashraf, Hasan Prottay, Muyeed Abdul, Taif Ali Md, Faysal Ahmed Fee, Islam Ariful, Maliha Rahman Maisha, Islam Mahfuza, Rahaman Khan Md Hasinur, Shafiqur Rahman M

机构信息

Institute of Statistical Research and Training, University of Dhaka, Dhaka 1000, Bangladesh.

International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR, B), Dhaka 1212, Bangladesh.

出版信息

Vaccine X. 2022 Dec;12:100207. doi: 10.1016/j.jvacx.2022.100207. Epub 2022 Aug 22.

Abstract

OBJECTIVE

One of the primary reasons for hesitancy in taking COVID-19 vaccines is the fear of side effects. This study primarily aimed to inspect the potential side effects of the COVID-19 vaccines circulated in Bangladesh.Design and Settings.The study was based on a cross-sectional anonymous online survey conducted in December 2021 across Bangladesh.Participants.The study included consenting Bangladeshi individuals aged 12 and above who had received at least one dose of the COVID-19 vaccines.Main Outcome.Analyses were carried out through exploratory analysis, Chi-square test, and logistic regression to investigate potential side effects of the COVID-19 vaccines.

RESULTS

A total of 1,180 vaccinated people participated in the study. Only 39.48% of the participants reported at least one side effect after receiving their COVID-19 vaccine. Injection-site pain, fever, headache, redness/swelling at the injection site, and lethargy were the most commonly reported adverse effects, all of which were mild and lasted 1-3 days. Side effects were most prevalent (about 80%) among individuals who received Pfizer-BioNTech and Moderna vaccines and were least common among those who received Sinopharm and Sinovac vaccines (21%-28%). When compared to the Sinopharm vaccines, the OxfordAstraZeneca, Pfizer-BioNTech, and Moderna vaccines were 4.51 times (95% CI: 2.53-8.04), 5.37 times (95% CI: 2.57-11.22), and 4.28 times (95% CI: 2.28-8.05) likelier to produce side effects. Furthermore, males, those over 50 years old, urban dwellers, smokers, and those with underlying health issues had a considerably increased risk of developing side effects. A lack of confidence in vaccines' efficacy and a substantial level of hesitancy in allowing children (age five years or over) and older people (70 years or over) to receive COVID-19 vaccines were also observed.

CONCLUSION

Side effects of COVID-19 vaccines are minimal, demonstrating their safety. Efforts should be made to disseminate such findings worldwide to increase vaccine uptake.

摘要

目的

对新冠疫苗接种犹豫不决的一个主要原因是担心副作用。本研究主要旨在调查在孟加拉国流通的新冠疫苗的潜在副作用。

设计与背景。该研究基于2021年12月在孟加拉国全国范围内进行的一项横断面匿名在线调查。

参与者。该研究纳入了年龄在12岁及以上、已接种至少一剂新冠疫苗且表示同意参与的孟加拉国个人。

主要结果。通过探索性分析、卡方检验和逻辑回归进行分析,以调查新冠疫苗的潜在副作用。

结果

共有1180名接种疫苗的人参与了该研究。只有39.48%的参与者在接种新冠疫苗后报告了至少一种副作用。注射部位疼痛、发热、头痛、注射部位发红/肿胀和嗜睡是最常报告的不良反应,所有这些反应都很轻微,持续1 - 3天。在接种辉瑞 - 生物科技公司和莫德纳疫苗的人群中,副作用最为普遍(约80%),而在接种国药集团和科兴疫苗的人群中最不常见(21% - 28%)。与国药集团疫苗相比,牛津 - 阿斯利康、辉瑞 - 生物科技公司和莫德纳疫苗产生副作用的可能性分别高4.51倍(95%置信区间:2.53 - 8.04)、5.37倍(95%置信区间:2.57 - 11.22)和4.28倍(95%置信区间:2.28 - 8.05)。此外,男性、50岁以上的人、城市居民、吸烟者以及有基础健康问题的人出现副作用的风险大幅增加。还观察到对疫苗效力缺乏信心,以及在允许儿童(5岁及以上)和老年人(70岁及以上)接种新冠疫苗方面存在相当程度的犹豫不决。

结论

新冠疫苗的副作用极小,证明了其安全性。应努力在全球传播此类研究结果,以提高疫苗接种率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f646/9429792/75700aa401a1/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验